市場調査レポート
商品コード
1389606

dPCRとqPCRの市場規模および予測、治療法、製品、用途、エンドユーザー、地域別の世界および地域シェア、動向、成長機会分析

dPCR and qPCR Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Product, Application, End User, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 159 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
dPCRとqPCRの市場規模および予測、治療法、製品、用途、エンドユーザー、地域別の世界および地域シェア、動向、成長機会分析
出版日: 2023年11月08日
発行: The Insight Partners
ページ情報: 英文 159 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

dPCRとqPCRの市場規模は、2022年の89億7,600万米ドルから2030年には182億3,000万米ドルに成長すると予測され、2022-2030年のCAGRは9.3%と推定されます。

dPCRとqPCR市場の成長は、遺伝病や感染症の発生率の増加、遺伝子合成への投資と資金の増加、PCR技術の技術的進歩に起因しています。

近年、PCRのような分子手法は診断技術として発展してきました。この方法はヘルスケア専門家が幅広い感染症を正確に診断することを可能にし、不可欠な研究・診断ツールと考えられています。PCR法は1本のDNAから数百万コピーのDNAを作り出すことができます。また、病気の早期診断が可能であるため、病気のコントロールに不可欠な役割を果たしています。PCRは異なる検査室間で比較可能な再現性のある結果をもたらし、それゆえ世界中で受け入れられています。PCR技術は新興国でも広く受け入れられ、利用されています。世界保健機関(WHO)の「発展途上国におけるPCR検査施設の設立に関する報告書2016」によると、WHOはWHO東南アジア諸国の全11加盟国にPCR検査施設を設立するために必要な技術支援を行っています。検査室は質の高い医療を提供するのに役立つと思われます。これらのPCR検査室は、逆転写酵素PCR(RT-PCR)、マルチプレックスPCR、リアルタイムPCR、In-situ PCR、デジタルPCR(dPCR)など、必要に応じてさまざまなPCR技術を採用しています。簡単、迅速、特異性の高い病気のスクリーニングと臨床微生物学、ウイルス学、寄生虫学、バイオテクノロジー、および関連分野での応用の増加により、新興諸国におけるdPCRとqPCR市場は予測期間中に有利な機会を経験すると予想されます。

液滴デジタルPCR(ddPCR)は、デジタルPCRを実行するための新しい技術です。水-油エマルジョン液滴技術を利用します。検査サンプルは約20,000の液滴に分画され、各液滴で標的DNA鎖の増幅が行われます。その後、ddPCRは個々の液滴中の核酸ターゲットをデジタル測定します。したがって、この技術は標的DNA分子の高精度で絶対的な定量を可能にし、診断や研究への幅広い応用を可能にします。qPCRでは、DNA定量はサイクル閾値(CT)から得られます。外部キャリブレーターが必要であり、不完全な増幅は絶対定量に影響します。Droplet Digital PCR(ddPCR)は検量線なしでターゲットDNAを直接カウントします。従って、ddPCRの出現により、科学者は複雑な遺伝的ランドスケープを探索し、新たな疾患との関連を発見し検証し、分子診断の新時代を定義することができるようになります。このように、ddPCRの市場開発は、将来dPCRとqPCR市場の大きな動向となると思われます。

用途に基づく洞察

用途に基づき、dPCRとqPCR市場は研究用途、臨床用途、法医学用途に区分されます。2022年には、臨床用途分野が市場で最大のシェアを占め、2022年から2030年にかけて最も高いCAGRを記録すると予測されています。分子生物学技術は疾病診断に革命をもたらし、今や検査室診断の重要な一部となっています。dPCRとqPCR技術は現在、糖尿病、感染症、がん、その他を含む多くの疾患の診断に使用されています。例えば、消化器感染症、院内感染症(HAI)、呼吸器感染症、性感染症などの診断には、リアルタイムPCR技術のリダジェネキットが開発されています。これらの分子的手法により、早期、高感度、特異的な診断が可能になるため、臨床応用分野は予測期間中に成長が見込まれます。

リアルタイムPCR技術は、遺伝子の変異を検出するために使用されており、がんの診断に役立っています。dPCRはまた、喀痰、尿、脳脊髄液、血漿などの無細胞DNA(cfDNA)サンプル中の腫瘍マーカーの正確な検出を可能にします。例えば、dPCRは上皮成長因子受容体(EGFR)、KRAS、ESR1の変異を検出するのに一般的に用いられています。

さらに、技術の進歩により、がんの診断や治療のための分子マーカーが提供されつつあります。2023年4月、サーモフィッシャーサイエンティフィックはQuantStudio Dxシリーズ用のCE-IVDマークを取得した37種類のリアルタイムPCRアッセイキットを発表し、多くの感染症を検出できるようになっています。

エンドユーザーに基づく洞察

dPCRとqPCR市場は、エンドユーザーに基づき、病院・診断センター、製薬・バイオテクノロジー企業、研究所・学術機関、法医学研究所、臨床研究機関に区分されます。2022年には、病院と診断センターセグメントが市場で最大のシェアを占め、2022-2030年に最も高いCAGRを記録すると予測されています。

dPCRとqPCR市場では、病院と診断センターが大きな市場シェアを占めています。dPCRとqPCRは、細菌、ウイルス、真菌を含む病原体の早期かつ正確な検出を可能にする高い感度と特異性などの利点を提供します。

さらに、病院は急性および慢性疾患の治療のために患者に高度な診断と治療の選択肢を提供しており、病院や診断センターは医療施設に専門的な科学機器を提供しているため、PCR技術の採用率は大幅に高くなっています。さらに、新興国における医療インフラの継続的な拡大、感染症の発生率の高さ、入院患者数の増加により、迅速で高感度な診断ツールの必要性が生じています。さらに、早期かつ効率的な疾病診断と治療に対する需要の高まり、診断用途のdPCR製品の上市数の増加、疾病診断におけるdPCRの利点(他のPCR技術と比較して)、臨床診断と疾病診断のためにこれらの技術が提供する利点に関する一般市民の意識の高まりが、市場の成長を後押ししています。

さらに、診断検査室にはハイテク機器が充実しており、検査する様々なサンプルのワークフローや管理が容易になっています。例えば、Thermo Fisher Scientific, Inc.は、QuantStudio 5、QuantStudio 6 Flex、QuantStudio 7、QuantStudio 12k、QuantStudio 3D、QuantStudio Absolute Q AutoRun dPCR Suiteなど、複数のPCRのバリエーションを提供しています。同様に、Bio-Rad Laboratories, Inc.、Fluidigm Corporation、Eppendorf、Agilent Technologies, Inc.などの数社は、病院や診断センターの能力や要求に応じてPCR装置を提供しています。

米国疾病予防管理センター(Centers for Disease Control and Prevention)、医学研究未来基金(Medical Research Future Fund)、世界保健機関(WHO)などは、dPCRとqPCR市場レポート作成時に参照した一次および二次調査情報の一つです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 dPCRとqPCR市場情勢

  • PEST分析
    • 世界のPEST分析

第5章 dPCRとqPCR市場- 主要産業力学

  • 市場促進要因
    • 遺伝病および感染症の発生率の増加
    • 遺伝子合成への投資と資金の増加
    • PCR技術の技術的進歩
  • 市場抑制要因
    • PCRシステムの高コスト
    • qPCRに伴う技術的限界
  • 市場機会
    • 新興国におけるPCR法の採用拡大
  • 今後の動向
    • 液滴デジタルPCRの発展
  • インパクト分析

第6章 dPCRとqPCR市場- 世界市場分析

  • dPCRとqPCR市場の収益、2022年~2030年

第7章 dPCRとqPCRの世界市場- 2030年までの収益と予測-治療別

  • dPCRとqPCR市場の収益シェア、治療別、2022年および2030年
  • 定量的PCR
  • デジタルPCR

第8章 dPCRとqPCRの世界市場- 2030年までの収益と予測- 製品別

  • dPCRとqPCR市場の収益シェア、製品別、2022年および2030年
  • 試薬・消耗品
  • 装置
  • ソフトウェア&サービス

第9章 dPCRとqPCRの世界市場- 2030年までの収益と予測-用途別

  • dPCRとqPCR市場の収益シェア、用途別、2022年および2030年
  • 調査用途
  • 臨床用途
  • 法医学用途

第10章 dPCRとqPCRの世界市場:2030年までの収益と予測- エンドユーザー別

  • dPCRとqPCR市場の収益シェア、エンドユーザー別、2022年および2030年
  • 病院および診断センター
  • 製薬会社およびバイオテクノロジー企業
  • 研究所および学術機関
  • 法医学研究所
  • 臨床研究機関

第11章 dPCRとqPCR市場:地域別分析

  • 北米
    • メキシコ
  • 欧州
    • その他欧州
  • アジア太平洋
    • その他アジア太平洋地域
  • 中東・アフリカ
    • その他中東とアフリカ
  • 中南米
    • その他中南米

第12章 dPCRとqPCR市場- 業界情勢

  • dPCRとqPCR市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第13章 企業プロファイル

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc
  • Genome Diagnostics Pvt Ltd

第14章 付録

図表

List Of Tables

  • Table 1. dPCR and qPCR Market Segmentation
  • Table 2. dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Mexico dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. UK dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. UK dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. UK dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. UK dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Germany dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Germany dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Germany dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Germany dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Germany dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. France dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. France dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. France dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. France dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. France dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Italy dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Italy dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Italy dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Italy dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Italy dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Spain dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Spain dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Spain dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Spain dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Spain dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Rest of Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Rest of Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Rest of Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Rest of Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Rest of Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. China dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. China dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. China dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. China dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. China dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Japan dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Japan dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Japan dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Japan dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Japan dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. India dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. India dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. India dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. India dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. India dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Australia dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. Australia dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Australia dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Australia dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Australia dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. South Korea dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. South Korea dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. South Korea dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. South Korea dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. South Korea dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. Rest of Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Rest of Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Middle East & Africa dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Middle East & Africa dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Middle East & Africa dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Middle East & Africa dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. Saudi Arabia dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Saudi Arabia dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Saudi Arabia dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Saudi Arabia dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Saudi Arabia dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. UAE dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. UAE dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. UAE dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. UAE dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. UAE dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. South Africa dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. South Africa dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. South Africa dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. South Africa dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. South Africa dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 113. Rest of Middle East & Africa dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Rest of Middle East & Africa dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Rest of Middle East & Africa dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 116. Rest of Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 117. Rest of Middle East & Africa dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 118. South & Central America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 119. South & Central America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 120. South & Central America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 121. South & Central America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 122. South & Central America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 123. Brazil dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 124. Brazil dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 125. Brazil dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 126. Brazil dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 127. Brazil dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 128. Argentina dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 129. Argentina dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 130. Argentina dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 131. Argentina dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 132. Argentina dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 133. Rest of South & Central America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 134. Rest of South & Central America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 135. Rest of South & Central America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of South & Central America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of South & Central America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Recent Organic Growth Strategies in dPCR and qPCR Market
  • Table 139. Recent Inorganic Growth Strategies in the dPCR and qPCR Market
  • Table 140. Glossary of Terms, dPCR and qPCR Market

List Of Figures

  • Figure 1. dPCR and qPCR Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. dPCR and qPCR Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. dPCR and qPCR Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 8. Quantitative PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Digital PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 11. Reagents & Consumables: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Instruments: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Software & Services: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 15. Research Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Clinical Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Forensic Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 19. Hospitals and Diagnostic Centers: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Research Laboratories and Academic Institutes: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Forensic Laboratories: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Clinical Research Organizations: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: dPCR and qPCR Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. North America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 27. US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Europe dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 31. Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Europe dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 33. UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Asia Pacific dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 40. Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Asia Pacific dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 42. China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Middle East & Africa dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 49. Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Middle East & Africa dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 51. Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. South & Central America dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 56. South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. South & Central America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 58. Brazil dCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Growth Strategies in dPCR and qPCR Market
目次
Product Code: TIPHE100000817

The dPCR and qPCR market size is expected to grow from US$ 8.976 billion in 2022 to US$ 18.230 billion by 2030; it is estimated to record a CAGR of 9.3% during 2022-2030.

The dPCR and qPCR market growth is attributed to the increasing incidence of genetic and infectious diseases, rising investments and funds for gene synthesis, and technological advancements in PCR technologies.

In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. According to the World Health Organization Report on the Establishment of PCR Laboratory in Developing Countries 2016, WHO is providing necessary technical assistance to establish PCR laboratories in all 11 member states of the WHO South East Asia countries. The laboratories will help in providing high-quality medical care. These PCR laboratories have adopted different PCR technologies such as Reverse transcriptase PCR (RT-PCR), Multiplex PCR, Real-time PCR, In-situ PCR, Digital PCR (dPCR), and others depending on their need. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.

Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, the development of ddPCR would become a major trend in the dPCR and qPCR market in the future.

Application-Based Insights

Based on application, the dPCR and qPCR market is segmented into research application, clinical application, and forensic application. In 2022, the clinical application segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2030. Molecular biology techniques have revolutionized disease diagnosis and are now a crucial part of laboratory diagnostics. The dPCR and qPCR techniques are now being used in the diagnosis of many diseases, including diabetes, infectious diseases, cancer, and others. For instance, real-time PCR technology RIDA GENE kits are developed for the diagnosis of gastrointestinal infections, hospital-acquired infections (HAI), respiratory infections, sexually transmitted infections, and other parameters. As these molecular methods allow early, sensitive, and specific diagnosis, the clinical application segment is expected to witness growth over the forecast period.

Real-time PCR technologies have been used to detect mutation in genes, which helps in the diagnosis of cancer. dPCR also enables precise detection of tumor markers in cell-free DNA (cfDNA) samples like sputum, urine, cerebrospinal fluid, plasma, and others. dPCR is more effective in detecting single-nucleotide polymorphism among the wild-type sequences. For example, dPCR is commonly used to detect mutation in epidermal growth factor receptor (EGFR), KRAS, and ESR1.

Furthermore, technological advancements are offering molecular markers for diagnosing and treating cancer. In April 2023, Thermo Fisher Scientific introduced 37 CE-IVD-marked real-time PCR assay kits for its QuantStudio Dx series of instruments to detect numerous infectious diseases.

End User-Based Insights

Based on end user, the dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. In 2022, the hospitals and diagnostic centers segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2030.

Hospitals and diagnostic centers contribute a significant market share to the dPCR and qPCR market. Hospitals are the primary centers for a patient seeking highly advanced treatment under the guidance of much-trained personnel. dPCR and qPCR offer advantages such as high sensitivity and specificity, allowing early and accurate detection of pathogens, including bacteria, viruses, and fungi.

In addition, hospitals offer advanced diagnosis and treatment options for patients to treat acute and chronic conditions, and the adoption of PCR techniques is much higher in hospitals and diagnostic centers as they provide healthcare facilities with specialized scientific equipment. Moreover, the continued expansion of healthcare infrastructure across emerging countries, the high incidences of infectious diseases, and the growing number of hospital admissions has created a need for rapid and sensitive diagnostic tools. Additionally, growing demand for early and efficient disease diagnosis and treatment, the increasing number of dPCR product launches for diagnostic applications, the advantages offered by dPCR in disease diagnosis (as compared to other PCR technologies), and growing awareness among public associated with the benefits offered by both these technologies for clinical and disease diagnosis fuel the market growth.

Furthermore, diagnostic laboratories are well-equipped with hi-tech equipment that enables easy workflow and management of various samples to be tested. For instance, Thermo Fisher Scientific, Inc. offers multiple variants of its PCR, including QuantStudio 5, QuantStudio 6 Flex, QuantStudio 7, QuantStudio 12k, QuantStudio 3D, and QuantStudio Absolute Q AutoRun dPCR Suite. Similarly, several companies, such as Bio-Rad Laboratories, Inc., Fluidigm Corporation, Eppendorf, and Agilent Technologies, Inc., offer PCR devices to hospitals and diagnostic centers based on their capacity and requirements.

Centers for Disease Control and Prevention, Medical Research Future Fund, and the World Health Organization (WHO) are among the primary and secondary sources referred to while preparing the dPCR and qPCR market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the dPCR and qPCR market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global dPCR and qPCR market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interests with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. dPCR and qPCR Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. dPCR and qPCR Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 5.1.2 Rising Investments and Funds for Gene Synthesis
    • 5.1.3 Technological Advancements in PCR Technologies
  • 5.2 Market Restraints
    • 5.2.1 High Costs of PCR Systems
    • 5.2.2 Technical Limitations Associated with qPCR
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 5.4 Future Trends
    • 5.4.1 Development of Droplet Digital PCR
  • 5.5 Impact Analysis:

6. dPCR and qPCR Market - Global Market Analysis

  • 6.1 dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

7. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 7.3 Quantitative PCR
    • 7.3.1 Overview
    • 7.3.2 Quantitative PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Digital PCR
    • 7.4.1 Overview
    • 7.4.2 Digital PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 8.1 Overview
  • 8.2 dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 8.3 Reagents & Consumables
    • 8.3.1 Overview
    • 8.3.2 Reagents & Consumables: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Instruments
    • 8.4.1 Overview
    • 8.4.2 Instruments: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Software & Services
    • 8.5.1 Overview
    • 8.5.2 Software & Services: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 9.3 Research Application
    • 9.3.1 Overview
    • 9.3.2 Research Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Clinical Application
    • 9.4.1 Overview
    • 9.4.2 Clinical Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 9.5 Forensic Application
    • 9.5.1 Overview
    • 9.5.2 Forensic Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 10.1 Overview
  • 10.2 dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 10.3 Hospitals and Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Diagnostic Centers: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical and Biotechnology Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research Laboratories and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research Laboratories and Academic Institutes: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Forensic Laboratories
    • 10.6.1 Overview
    • 10.6.2 Forensic Laboratories: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.7 Clinical Research Organizations
    • 10.7.1 Overview
    • 10.7.2 Clinical Research Organizations: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

11. dPCR and qPCR Market - Geographical Analysis

  • 11.1 North America dPCR and qPCR Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.1.4 North America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.1.5 North America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.1.5.1 North America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.1.6 North America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.6.1 North America dPCR and qPCR Market, by Country
      • 11.1.6.2 US
        • 11.1.6.2.1 US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.2.2 US: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.6.2.3 US: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.6.2.4 US: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.6.2.4.1 US: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.6.2.5 US: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.6.3 Canada
        • 11.1.6.3.1 Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.3.2 Canada: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.6.3.3 Canada: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.6.3.4 Canada: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.6.3.4.1 Canada: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.6.3.5 Canada: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.6.4 Mexico
        • 11.1.6.4.1 Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.4.2 Mexico: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.6.4.3 Mexico: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.6.4.4 Mexico: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.6.4.4.1 Mexico: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.6.4.5 Mexico: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.2 Europe dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.2.4 Europe: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.2.5 Europe: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.2.5.1 Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.2.6 Europe: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.1 Europe dPCR and qPCR Market, by Country
      • 11.2.6.2 UK
        • 11.2.6.2.1 UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.2.2 UK: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.2.3 UK: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.2.4 UK: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.2.4.1 UK: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.2.5 UK: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.3 Germany
        • 11.2.6.3.1 Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.3.2 Germany: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.3.3 Germany: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.3.4 Germany: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.3.4.1 Germany: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.3.5 Germany: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.4 France
        • 11.2.6.4.1 France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.4.2 France: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.4.3 France: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.4.4 France: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.4.4.1 France: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.4.5 France: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.5 Italy
        • 11.2.6.5.1 Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.5.2 Italy: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.5.3 Italy: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.5.4 Italy: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.5.4.1 Italy: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.5.5 Italy: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.6 Spain
        • 11.2.6.6.1 Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.6.2 Spain: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.6.3 Spain: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.6.4 Spain: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.6.4.1 Spain: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.6.5 Spain: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.7 Rest of Europe
        • 11.2.6.7.1 Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.7.2 Rest of Europe: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.7.3 Rest of Europe: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.7.4 Rest of Europe: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.7.4.1 Rest of Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.7.5 Rest of Europe: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.3 Asia Pacific dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.3.5.1 Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.3.6 Asia Pacific: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.1 Asia Pacific dPCR and qPCR Market, by Country
      • 11.3.6.2 China
        • 11.3.6.2.1 China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.2.2 China: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.2.3 China: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.2.4 China: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.2.4.1 China: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.2.5 China: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.3 Japan
        • 11.3.6.3.1 Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.3.2 Japan: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.3.3 Japan: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.3.4 Japan: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.3.4.1 Japan: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.3.5 Japan: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.4 India
        • 11.3.6.4.1 India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.4.2 India: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.4.3 India: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.4.4 India: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.4.4.1 India: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.4.5 India: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.5 Australia
        • 11.3.6.5.1 Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.5.2 Australia: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.5.3 Australia: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.5.4 Australia: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.5.4.1 Australia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.5.5 Australia: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.6 South Korea
        • 11.3.6.6.1 South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.6.2 South Korea: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.6.3 South Korea: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.6.4 South Korea: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.6.4.1 South Korea: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.6.5 South Korea: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.7 Rest of Asia Pacific
        • 11.3.6.7.1 Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.7.2 Rest of Asia Pacific: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.7.3 Rest of Asia Pacific: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.7.4 Rest of Asia Pacific: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.7.4.1 Rest of Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.7.5 Rest of Asia Pacific: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.4.5.1 Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.4.6 Middle East & Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.1 Middle East & Africa dPCR and qPCR Market, by Country
      • 11.4.6.2 Saudi Arabia
        • 11.4.6.2.1 Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.2.2 Saudi Arabia: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.2.3 Saudi Arabia: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.2.4 Saudi Arabia: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.2.4.1 Saudi Arabia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.2.5 Saudi Arabia: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.3 UAE
        • 11.4.6.3.1 UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.3.2 UAE: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.3.3 UAE: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.3.4 UAE: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.3.4.1 UAE: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.3.5 UAE: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.4 South Africa
        • 11.4.6.4.1 South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.4.2 South Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.4.3 South Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.4.4 South Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.4.4.1 South Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.4.5 South Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.5 Rest of Middle East & Africa
        • 11.4.6.5.1 Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.5.2 Rest of Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.5.3 Rest of Middle East & Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.5.4 Rest of Middle East & Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.5.4.1 Rest of Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.5.5 Rest of Middle East & Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.5 South & Central America dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.5.5.1 South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.5.6 South & Central America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.5.6.1 South & Central America dPCR and qPCR Market, by Country
      • 11.5.6.2 Brazil
        • 11.5.6.2.1 Brazil dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.2.2 Brazil: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.5.6.2.3 Brazil: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.5.6.2.4 Brazil: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.5.6.2.4.1 Brazil: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.5.6.2.5 Brazil: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.5.6.3 Argentina
        • 11.5.6.3.1 Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.3.2 Argentina: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.5.6.3.3 Argentina: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.5.6.3.4 Argentina: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.5.6.3.4.1 Argentina: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.5.6.3.5 Argentina: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.5.6.4 Rest of South & Central America
        • 11.5.6.4.1 Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.4.2 Rest of South & Central America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.5.6.4.3 Rest of South & Central America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.5.6.4.4 Rest of South & Central America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.5.6.4.4.1 Rest of South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.5.6.4.5 Rest of South & Central America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

12. dPCR and qPCR Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in dPCR and qPCR Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Thermo Fisher Scientific Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Takara Bio Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Qiagen NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Standard BioTools Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Lepu Medical Technology Beijing Co Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 F. Hoffmann-La Roche Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Bio-Rad Laboratories Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Agilent Technologies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Genome Diagnostics Pvt Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 SWOT Analysis
    • 13.10.5 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms